vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and HA Sustainable Infrastructure Capital, Inc. (HASI). Click either name above to swap in a different company.
AVANOS MEDICAL, INC. is the larger business by last-quarter revenue ($180.9M vs $114.8M, roughly 1.6× HA Sustainable Infrastructure Capital, Inc.). AVANOS MEDICAL, INC. runs the higher net margin — -0.7% vs -46.8%, a 46.1% gap on every dollar of revenue. On growth, HA Sustainable Infrastructure Capital, Inc. posted the faster year-over-year revenue change (13.3% vs 0.7%). Over the past eight quarters, AVANOS MEDICAL, INC.'s revenue compounded faster (4.4% CAGR vs 4.2%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
HA Sustainable Infrastructure Capital, Inc. (HASI) is a specialized investment firm focused on sustainable infrastructure assets covering renewable energy, energy efficiency, sustainable real estate and low-carbon utility segments. It primarily operates in North American markets, providing long-term capital to eligible sustainable projects and delivering stable risk-adjusted returns to investors through recurring cash flows from operational underlying assets.
AVNS vs HASI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $114.8M |
| Net Profit | $-1.3M | $-53.8M |
| Gross Margin | 47.5% | — |
| Operating Margin | 1.4% | -57.4% |
| Net Margin | -0.7% | -46.8% |
| Revenue YoY | 0.7% | 13.3% |
| Net Profit YoY | 99.7% | -176.7% |
| EPS (diluted) | $-0.02 | $-0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $180.9M | $114.8M | ||
| Q3 25 | $177.8M | $103.1M | ||
| Q2 25 | $175.0M | $85.7M | ||
| Q1 25 | $167.5M | $96.9M | ||
| Q4 24 | $179.6M | $101.3M | ||
| Q3 24 | $170.4M | $82.0M | ||
| Q2 24 | $171.7M | $94.5M | ||
| Q1 24 | $166.1M | $105.8M |
| Q4 25 | $-1.3M | $-53.8M | ||
| Q3 25 | $-1.4M | $83.3M | ||
| Q2 25 | $-76.8M | $98.4M | ||
| Q1 25 | $6.6M | $56.6M | ||
| Q4 24 | $-397.3M | $70.1M | ||
| Q3 24 | $4.3M | $-19.6M | ||
| Q2 24 | $1.8M | $26.5M | ||
| Q1 24 | $-900.0K | $123.0M |
| Q4 25 | 47.5% | — | ||
| Q3 25 | 48.4% | — | ||
| Q2 25 | 52.6% | — | ||
| Q1 25 | 53.6% | — | ||
| Q4 24 | 54.6% | — | ||
| Q3 24 | 54.5% | — | ||
| Q2 24 | 55.7% | — | ||
| Q1 24 | 57.1% | — |
| Q4 25 | 1.4% | -57.4% | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | -42.6% | — | ||
| Q1 25 | 6.1% | 84.7% | ||
| Q4 24 | -233.0% | 90.9% | ||
| Q3 24 | 7.0% | -32.1% | ||
| Q2 24 | 3.7% | 39.5% | ||
| Q1 24 | 2.4% | — |
| Q4 25 | -0.7% | -46.8% | ||
| Q3 25 | -0.8% | 80.8% | ||
| Q2 25 | -43.9% | 114.9% | ||
| Q1 25 | 3.9% | 58.4% | ||
| Q4 24 | -221.2% | 69.2% | ||
| Q3 24 | 2.5% | -23.9% | ||
| Q2 24 | 1.0% | 28.1% | ||
| Q1 24 | -0.5% | 116.3% |
| Q4 25 | $-0.02 | $-0.38 | ||
| Q3 25 | $-0.03 | $0.61 | ||
| Q2 25 | $-1.66 | $0.74 | ||
| Q1 25 | $0.14 | $0.44 | ||
| Q4 24 | $-8.64 | $0.58 | ||
| Q3 24 | $0.09 | $-0.17 | ||
| Q2 24 | $0.04 | $0.23 | ||
| Q1 24 | $-0.02 | $0.98 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $110.2M |
| Total DebtLower is stronger | $90.3M | — |
| Stockholders' EquityBook value | $778.2M | $2.7B |
| Total Assets | $1.1B | $8.2B |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.8M | $110.2M | ||
| Q3 25 | $70.5M | $301.8M | ||
| Q2 25 | $90.3M | $86.5M | ||
| Q1 25 | $97.0M | $67.4M | ||
| Q4 24 | $107.7M | $129.8M | ||
| Q3 24 | $89.0M | $44.1M | ||
| Q2 24 | $92.2M | $145.7M | ||
| Q1 24 | $75.8M | $61.4M |
| Q4 25 | $90.3M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $95.7M | — | ||
| Q1 25 | $98.0M | — | ||
| Q4 24 | $125.3M | — | ||
| Q3 24 | $152.6M | — | ||
| Q2 24 | $164.9M | — | ||
| Q1 24 | $167.2M | — |
| Q4 25 | $778.2M | $2.7B | ||
| Q3 25 | $778.0M | $2.7B | ||
| Q2 25 | $776.3M | $2.6B | ||
| Q1 25 | $839.4M | $2.5B | ||
| Q4 24 | $828.5M | $2.4B | ||
| Q3 24 | $1.2B | $2.3B | ||
| Q2 24 | $1.2B | $2.3B | ||
| Q1 24 | $1.2B | $2.3B |
| Q4 25 | $1.1B | $8.2B | ||
| Q3 25 | $1.1B | $8.2B | ||
| Q2 25 | $1.0B | $7.6B | ||
| Q1 25 | $1.1B | $7.5B | ||
| Q4 24 | $1.2B | $7.1B | ||
| Q3 24 | $1.7B | $6.7B | ||
| Q2 24 | $1.7B | $6.7B | ||
| Q1 24 | $1.7B | $6.7B |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $167.3M |
| Free Cash FlowOCF − Capex | $21.3M | — |
| FCF MarginFCF / Revenue | 11.8% | — |
| Capex IntensityCapex / Revenue | 3.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $167.3M | ||
| Q3 25 | $14.0M | $-121.8M | ||
| Q2 25 | $6.8M | $79.6M | ||
| Q1 25 | $25.7M | $-37.1M | ||
| Q4 24 | $57.9M | $5.9M | ||
| Q3 24 | $23.0M | $21.9M | ||
| Q2 24 | $27.8M | $-24.8M | ||
| Q1 24 | $-8.0M | $20.9M |
| Q4 25 | $21.3M | — | ||
| Q3 25 | $7.0M | — | ||
| Q2 25 | $-4.2M | — | ||
| Q1 25 | $19.0M | — | ||
| Q4 24 | $53.1M | — | ||
| Q3 24 | $20.0M | — | ||
| Q2 24 | $21.9M | — | ||
| Q1 24 | $-12.1M | — |
| Q4 25 | 11.8% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | -2.4% | — | ||
| Q1 25 | 11.3% | — | ||
| Q4 24 | 29.6% | — | ||
| Q3 24 | 11.7% | — | ||
| Q2 24 | 12.8% | — | ||
| Q1 24 | -7.3% | — |
| Q4 25 | 3.8% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | 6.3% | — | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 1.8% | — | ||
| Q2 24 | 3.4% | — | ||
| Q1 24 | 2.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.46× | ||
| Q2 25 | — | 0.81× | ||
| Q1 25 | 3.89× | -0.66× | ||
| Q4 24 | — | 0.08× | ||
| Q3 24 | 5.35× | — | ||
| Q2 24 | 15.44× | -0.94× | ||
| Q1 24 | — | 0.17× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
HASI
Segment breakdown not available.
